Silvina B Nadin

Dr. Silvina B Nadin

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2001 in Journal of Histochemistry & Cytochemistry
Verified
Journal Article
Open access
PDF file
SNSilvina B Nadin
Silvina B Nadin
LVLaura M. Vargas–Roig
Laura M. Vargas–Roig
DCDaniel R. Ciocca
Daniel R. Ciocca
The single-cell gel assay (comet assay) is a very useful microelectrophoretic technique for evaluation of DNA damage and repair in individual cells. Usually, the comets are visualized and evaluated with fluorescent DNA stains. This staining requires specific equipment (e.g., a high-quality fluorescence microscope), the slides must be analyzed immediately, and they cannot be stored for long periods of time. Here we describe, using human lymphocytes, some modifications of the silver staining for comets that significantly increase the sensitivity/reproducibility of the assay. This silver staining was compared with fluorescence staining and commercial silver stains. (J Histochem Cytochem 49:1183–1186, 2001)

26 September 2017 in Cell Stress and Chaperones
Verified
Journal Article
Open access
PDF file
MSMayra L. Sottile
Mayra L. Sottile
SNSilvina B Nadin
Silvina B Nadin
Heat shock proteins (HSPs), also known as molecular chaperones, participate in important cellular processes, such as protein aggregation, disaggregation, folding, and unfolding. HSPs have cytoprotective functions that are commonly explained by their antiapoptotic role. Their involvement in anticancer drug resistance has been the focus of intense research efforts, and the relationship between HSP induction and DNA repair mechanisms has been in the spotlight during the past decades. Because DNA is permanently subject to damage, many DNA repair pathways are involved in the recognition and removal of a diverse array of DNA lesions. Hence, DNA repair mechanisms are key to maintain genome stability. In addition, the interactome network of HSPs with DNA repair proteins has become an exciting research field and so their use as emerging targets for cancer therapy. This article provides a historical overview of the participation of HSPs in DNA repair mechanisms as part of their molecular chaperone capabilities.

1 May 2004 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
MBMarı́a Teresita Branham
Marı́a Teresita Branham
SNSilvina B Nadin
Silvina B Nadin
LVLaura Marı́a Vargas-Roig
Laura Marı́a Vargas-Roig
DCDaniel Ramón Ciocca
Daniel Ramón Ciocca

1 March 2015 in Cell Stress and Chaperones
Verified
Journal Article
Open access
PDF file
GCGisela Natalia Castro
Gisela Natalia Castro
NCNiubys Cayado-Gutiérrez
Niubys Cayado-Gutiérrez
FZFelipe Carlos Martin Zoppino
Felipe Carlos Martin Zoppino
MFMariel Andrea Fanelli
Mariel Andrea Fanelli
FCFernando Darío Cuello-Carrión
Fernando Darío Cuello-Carrión
DCDaniel Ramón Ciocca
Daniel Ramón Ciocca
We previously reported the association of HSPA1A and HSPB1 with high-grade astrocytomas, suggesting that these proteins might be involved in disease outcome and response to treatment. With the aim to better understand the resistance/susceptibility processes associated to temozolomide (TMZ) treatment, the current study was performed in three human malignant glioma cell lines by focusing on several levels: (a) apoptotic index and senescence, (b) DNA damage, and (c) interaction of HSPB1 with players of the DNA damage response. Three human glioma cell lines, Gli36, U87, and DBTRG, were treated with TMZ evaluating cell viability and survival, apoptosis, senescence, and comets (comet assay). The expression of HSPA (HSPA1A and HSPA8), HSPB1, O6-methylguanine-DNA methyltransferase (MGMT), MLH1, and MSH2 was determined by immunocytochemistry, immunofluorescence, and Western blot. Immunoprecipitation was used to analyze protein interaction. The cell lines exhibited differences in viability, apoptosis, and senescence after TMZ administration. We then focused on Gli36 cells (relatively unstudied) which showed very low recovery capacity following TMZ treatment, and this was related to high DNA damage levels; however, the cells maintained their viability. In these cells, MGMT, MSH2, HSPA, and HSPB1 levels increased significantly after TMZ administration. In addition, MSH2 and HSPB1 proteins appeared co-localized by confocal microscopy. This co-localization increased after TMZ treatment, and in immunoprecipitation analysis, MSH2 and HSPB1 appeared interacting. In contrast, HSPB1 did not interact with MGMT. We show in glioma cells the biological effects of TMZ and how this drug affects the expression levels of heat shock proteins (HSPs), MGMT, MSH2, and MLH1. In Gli36 cells, the results suggest that interactions between HSPB1 and MSH2, including co-nuclear localization, may be important in determining cell sensitivity to TMZ.

28 July 2006 in Cancer Letters
Verified
Journal Article
Closed access
SNSilvina B Nadin
Silvina B Nadin
LVL Vargasroig
L Vargasroig
GDG Drago
G Drago
JIJ Ibarra
J Ibarra
DCD Ciocca
D Ciocca

10 April 2014 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
MFMarina Ines Flamini
Marina Ines Flamini
GGGisel Valeria Gauna
Gisel Valeria Gauna
MSMayra Lis Sottile
Mayra Lis Sottile
SNSilvina B Nadin
Silvina B Nadin
ASAngel Matias Sanchez
Angel Matias Sanchez
LVLaura María Vargas‐Roig
Laura María Vargas‐Roig
Breast cancer is the most common malignancy in women and the appearance of distant metastases produces the death in 98% of cases. The retinoic acid receptor β (RARβ) is not expressed in 50% of invasive breast carcinoma compared with normal tissue and it has been associated with lymph node metastasis. Our hypothesis is that RARβ protein participates in the metastatic process. T47D and MCF7 breast cancer cell lines were used to perform viability assay, immunobloting, migration assays, RNA interference and immunofluorescence. Administration of retinoic acid (RA) in breast cancer cells induced RARβ gene expression that was greatest after 72 hrs with a concentration 1 μM. High concentrations of RA increased the expression of RARβ causing an inhibition of the 60% in cell migration and significantly decreased the expression of migration‐related proteins [moesin, c‐Src and focal adhesion kinase (FAK)]. The treatment with RARα and RARγ agonists did not affect the cell migration. On the contrary, the addition of the selective retinoid RARβ‐agonist (BMS453) significantly reduced cell migration comparable to RA inhibition. When RARβ gene silencing was performed, the RA failed to significantly inhibit migration and resulted ineffective to reduce moesin, c‐Src and FAK expressions. RARβ is necessary to inhibit migration induced by RA in breast cancer cells modulating the expression of proteins involved in cell migration.